Lowe Wealth Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Lowe Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$1.37K	Hold	68	–	–	﹤0.01%	354
2025 Q2	$1.14K	Hold	68	–	–	﹤0.01%	340
2025 Q1	$1.04K	Hold	68	–	–	﹤0.01%	347
2024 Q4	$1.5K	Hold	68	–	–	﹤0.01%	331
2024 Q3	$1.22K	Hold	68	–	–	﹤0.01%	291
2024 Q2	$1.1K	Hold	68	–	–	﹤0.01%	288
2024 Q1	$958	Hold	68	–	–	﹤0.01%	281
2023 Q4	$709	Hold	68	–	–	﹤0.01%	290
2023 Q3	$693	Hold	68	–	–	﹤0.01%	283
2023 Q2	$511	Hold	68	–	–	﹤0.01%	332
2023 Q1	$601	Hold	68	–	–	﹤0.01%	327
2022 Q4	$619	Sell	68 -350	-84%	-$3.05K	﹤0.01%	326
2022 Q3	$3K	Hold	418	–	–	﹤0.01%	286
2022 Q2	$3K	Hold	418	–	–	﹤0.01%	268
2022 Q1	$4K	Hold	418	–	–	﹤0.01%	264
2021 Q4	$3K	Buy	418 +350	+515%	+$3.16K	﹤0.01%	259
2021 Q3	$1K	Hold	68	–	–	﹤0.01%	278
2021 Q2	$1K	Hold	68	–	–	﹤0.01%	272
2021 Q1	$1K	Hold	68	–	–	﹤0.01%	267
2020 Q4	$1K	Hold	68	–	–	﹤0.01%	260
2020 Q3	$1K	Hold	68	–	–	﹤0.01%	257
2020 Q2	$1K	Hold	68	–	–	﹤0.01%	256
2020 Q1	$1K	Hold	68	–	–	﹤0.01%	287
2019 Q4	$1K	Hold	68	–	–	﹤0.01%	286
2019 Q3	$0	Hold	68	–	–	﹤0.01%	302
2019 Q2	$1K	Buy	68 +1	+1%	+$12	﹤0.01%	283
2019 Q1	$1K	Sell	67 -1	-1%	-$18	﹤0.01%	262
2018 Q4	$1K	Hold	68	–	–	﹤0.01%	244
2018 Q3	$1K	Hold	68	–	–	﹤0.01%	281
2018 Q2	$2K	Hold	68	–	–	﹤0.01%	210
2018 Q1	$1K	Hold	68	–	–	﹤0.01%	235
2017 Q4	$1K	Hold	68	–	–	﹤0.01%	241
2017 Q3	$1K	Buy	68 +1	+1%	+$23	﹤0.01%	233
2017 Q2	$2K	Hold	67	–	–	﹤0.01%	192
2017 Q1	$2K	Buy	67 +1	+2%	+$34	﹤0.01%	191
2016 Q4	$2K	Hold	66	–	–	﹤0.01%	196
2016 Q3	$3K	Buy	66 +1	+2%	+$52	﹤0.01%	193
2016 Q2	$3K	Hold	65	–	–	﹤0.01%	189
2016 Q1	$3K	Hold	65	–	–	﹤0.01%	178
2015 Q4	$4K	Buy	65 +1	+2%	+$62	﹤0.01%	173
2015 Q3	$4K	Hold	64	–	–	﹤0.01%	171
2015 Q2	$4K	Hold	64	–	–	﹤0.01%	168
2015 Q1	$4K	Buy	64 +1	+2%	+$58	﹤0.01%	170
2014 Q4	$4K	Buy	+63	New	+$3.51K	﹤0.01%	154

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

Lowe Wealth Advisors's TEVA Position: Q3 2025 in Review

Lowe Wealth Advisors held its Teva Pharmaceuticals (TEVA) position steady in Q3 2025 at 68 shares worth $1.37K. The position accounts for ﹤0.01% of the portfolio, ranked #354.

Lowe Wealth Advisors first reported a position in TEVA in Q4 2014 and has held it in 44 quarters since. The position peaked at $4K in Q1 2022. 551 funds tracked by Wall St. Rank hold TEVA as of Q3 2025.

Lowe Wealth Advisors held 68 shares of Teva Pharmaceuticals worth $1.37K as of Q3 2025.
Lowe Wealth Advisors left its Teva Pharmaceuticals share count unchanged in Q3 2025.
Teva Pharmaceuticals made up ﹤0.01% of Lowe Wealth Advisors's portfolio in Q3 2025, its #354 holding.
Lowe Wealth Advisors first reported a position in Teva Pharmaceuticals in Q4 2014 and has held it in 44 quarters since.
Lowe Wealth Advisors's Teva Pharmaceuticals position peaked at $4K in Q1 2022.
551 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2025.

Based on Lowe Wealth Advisors's 13F filing for Q3 2025, filed 16 Oct 2025.